Data search
Results for MligTC455_41805
| Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
|---|---|---|---|---|---|---|
| MligTC455_41805 | 2256 | 47.00 | Mlig455_015764, Mlig455_049489 | Neo: - Age: - Region-specific R8: 2.792 Region-enriched R8: 2.927/0.00000 |
PKD2 | Mlig455_015764 {REF} {Length: 3347} {Pfam: Polycystin cation channel [PF08016.14, score=395.7]; Ion transport protein [PF00520.33, score=60.8]; EF hand [PF00036.34, score=22.8]; Ferredoxin I 4Fe-4S cluster domain [PF18109.3, score=20.9]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [Score=618, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [Score=617, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=255, Expect=3e-72]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [Score=338, Expect=2e-104]} {Smed: dd_Smed_v6_17348_0_3, dd_Smed_v6_17348_0_3, [Score=660, Expect=0.0]} {RNA1509_31010} {RNA1310_4653.2} {RNA815_18688} Mlig455_049489 {REF} {Length: 3379} {Pfam: Polycystin cation channel [PF08016.14, score=493.3]; Ion transport protein [PF00520.33, score=89.5]; EF hand [PF00036.34, score=27.1]; Ferredoxin I 4Fe-4S cluster domain [PF18109.3, score=20.9]; EF-hand domain [PF13405.8, score=18.5]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=716, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [RH, Score=711, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=306, Expect=1e-90]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [RH, Score=387, Expect=1e-122]} {Smed: dd_Smed_v6_17348_0_3, dd_Smed_v6_17348_0_3, [RH, Score=739, Expect=0.0]} {RNA1509_31010, RNA1509_51627} {RNA1310_4653.1, RNA1509_31010, RNA1509_51627} {RNA1509_31010, RNA1509_51627, RNA815_4316} |
Cumulative graph for MligTC455_41805
Region-enriched expression
| Region | logFC | logCPM | Pvalue | FDR | Specificity |
|---|---|---|---|---|---|
| RegionR1 | -0.692 | 5.622 | 0.34060 | 0.98545 | |
| RegionR2 | 0.374 | 5.622 | 0.30356 | 0.69379 | |
| RegionR3 | -1.325 | 5.622 | 0.00004 | 0.00220 | |
| RegionR4 | -2.06 | 5.622 | 0.00000 | 0.00000 | |
| RegionR5 | -1.308 | 5.622 | 0.00001 | 0.00019 | |
| RegionR6 | -0.11 | 5.622 | 0.70918 | 1.00000 | |
| RegionR7 | 2.195 | 5.622 | 0.00000 | 0.00000 | Specific for R7: 2.392 |
| RegionR8 | 2.927 | 5.622 | 0.00000 | 0.00000 | Specific for R8: 2.792 |
Regeneration-enriched expression
| Region | logFC | logCPM | PValue | FDR | Specificity |
|---|---|---|---|---|---|
| RegenerationR1 | -1.305 | 5.622 | 0.39268 | 1.00000 | |
| RegenerationR2 | -0.644 | 5.622 | 0.06194 | 0.40833 | |
| RegenerationR3 | 0.54 | 5.622 | 0.17579 | 0.61159 | |
| RegenerationR4 | 0.246 | 5.622 | 0.53940 | 0.88828 | |
| RegenerationR5 | 0.493 | 5.622 | 0.18060 | 0.61058 | |
| RegenerationR6 | -0.424 | 5.622 | 0.27117 | 0.62141 | |
| RegenerationBL | -1.314 | 5.622 | 0.00057 | 0.01545 | |
| RegenerationTP | -0.951 | 5.622 | 0.00766 | 0.14695 |
Genes with expression patterns similar to MligTC455_41805
| Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | MligTC455_41805 | 2256 | 47 | Mlig455_015764, Mlig455_049489 | Neo: - Age: - Region-specific R8: 2.792 Region-enriched R8: 2.927/0.00000 |
PKD2 | 6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_015764 {REF} {Length: 3347} {Pfam: Polycystin cation channel [PF08016.14, score=395.7]; Ion transport protein [PF00520.33, score=60.8]; EF hand [PF00036.34, score=22.8]; Ferredoxin I 4Fe-4S cluster domain [PF18109.3, score=20.9]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [Score=618, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [Score=617, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=255, Expect=3e-72]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [Score=338, Expect=2e-104]} {Smed: dd_Smed_v6_17348_0_3, dd_Smed_v6_17348_0_3, [Score=660, Expect=0.0]} {RNA1509_31010} {RNA1310_4653.2} {RNA815_18688} Mlig455_049489 {REF} {Length: 3379} {Pfam: Polycystin cation channel [PF08016.14, score=493.3]; Ion transport protein [PF00520.33, score=89.5]; EF hand [PF00036.34, score=27.1]; Ferredoxin I 4Fe-4S cluster domain [PF18109.3, score=20.9]; EF-hand domain [PF13405.8, score=18.5]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=716, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [RH, Score=711, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=306, Expect=1e-90]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [RH, Score=387, Expect=1e-122]} {Smed: dd_Smed_v6_17348_0_3, dd_Smed_v6_17348_0_3, [RH, Score=739, Expect=0.0]} {RNA1509_31010, RNA1509_51627} {RNA1310_4653.1, RNA1509_31010, RNA1509_51627} {RNA1509_31010, RNA1509_51627, RNA815_4316} |
| 2. | MligTC455_45987 | 1592 | 33.17 | Mlig455_024379, Mlig455_024495 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.664 Region-specific R8: 3.405 Region-enriched R8: 3.716/0.00000 Regeneration-depleted BL: -2.612 |
PKDREJ | 4.937 | 0.980 | 0.797 | 0.886 | 0.704 | 0.734 | 0.836 | Mlig455_024379 {REF} {Length: 9101} {Pfam: PKD domain [PF18911.2, score=34.9]; PKD domain [PF00801.22, score=21.5]} {RNA1509_1257} {RNA1310_126.1} {RNA815_58} Mlig455_024495 {REF} {Length: 8484} {Pfam: Polycystin cation channel [PF08016.14, score=333.9]; PLAT/LH2 domain [PF01477.25, score=69.5]; PKD domain [PF18911.2, score=32.8]; Ion transport protein [PF00520.33, score=31.6]; PKD domain [PF00801.22, score=19.8]} {Human: ENSG00000130943, PKDREJ, polycystin family receptor for egg jelly, [RH, Score=346, Expect=8e-95]} {Mouse: ENSMUSG00000052496, Pkdrej, polycystin (PKD) family receptor for egg jelly, [RH, Score=327, Expect=4e-89]; ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [RH, Score=319, Expect=7e-87]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=167, Expect=3e-41]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [Score=198, Expect=3e-52]} {Smed: dd_Smed_v6_10962_0_1, dd_Smed_v6_10962_0_1, [Score=592, Expect=9e-172]} {RNA1509_1257} {RNA1310_126.1} {RNA815_58} |
| 3. | MligTC455_41806 | 792 | 16.49 | Mlig455_049483 | Neo: - Age: logFC(26M/2M)=-0.238 Region-enriched R8: 2.716/0.00000 |
PKD2 | 4.171 | 0.958 | 0.847 | 0.865 | - | 0.724 | 0.777 | Mlig455_049483 {REF} {Length: 3737} {Pfam: Polycystin cation channel [PF08016.14, score=493.1]; Ion transport protein [PF00520.33, score=89.6]; EF hand [PF00036.34, score=22.8]; Ferredoxin I 4Fe-4S cluster domain [PF18109.3, score=20.9]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [Score=712, Expect=0.0]; ENSG00000107593, PKD2L1, polycystin 2 like 1, transient receptor potential cation channel, [Score=694, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [Score=709, Expect=0.0]; ENSMUSG00000037578, Pkd2l1, polycystic kidney disease 2-like 1, [Score=692, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=306, Expect=2e-90]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [RH, Score=389, Expect=7e-124]} {Smed: dd_Smed_v6_17348_0_3, dd_Smed_v6_17348_0_3, [RH, Score=747, Expect=0.0]} {RNA1509_31010, RNA1509_33992} {RNA1310_4653.1, RNA1509_33992} {RNA1509_33992, RNA815_4316} |
| 4. | MligTC455_53279 | 2935 | 61.14 | Mlig455_017965 | Neo: - Age: Down-Up-Down Region-specific R8: 3.606 Region-enriched R8: 3.165/0.00000 Regeneration-downregulated BL: -2.902 Regeneration-depleted BL: -2.902 |
3.674 | 0.979 | 0.885 | 0.844 | - | - | 0.966 | Mlig455_017965 {REF} {Length: 1023} {RNA1509_20769, RNA1509_34269} {RNA1310_44808, RNA1509_20769, RNA1509_34269} {RNA1509_20769, RNA1509_34269, RNA815_8213} | |
| 5. | MligTC455_20781 | 5503 | 114.65 | Mlig455_066518 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.978 Region-enriched R8: 6.430/0.00000 |
FBN2 | 3.504 | 0.967 | 0.812 | 0.795 | - | - | 0.930 | Mlig455_066518 {REF} {Length: 6133} {Pfam: EGF domain [PF12947.9, score=539.9]; Calcium-binding EGF domain [PF07645.17, score=534.2]; Complement Clr-like EGF-like [PF12662.9, score=301.4]; EGF-like domain [PF00008.29, score=202.5]; Human growth factor-like EGF [PF12661.9, score=158.8]; MSP1 EGF domain 1 [PF12946.9, score=133.7]; Coagulation Factor Xa inhibitory site [PF14670.8, score=101.2]; Pvs28 EGF domain [PF06247.13, score=76.5]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=27.8]} {Human: ENSG00000138829, FBN2, fibrillin 2, [Score=348, Expect=8e-98]} {Mouse: ENSMUSG00000024598, Fbn2, fibrillin 2, [Score=350, Expect=2e-98]} {Dmel: FBgn0053196, dpy, dumpy, [Score=343, Expect=2e-96]} {Celegans: WBGene00022816, fbn-1, FBN-1A.1; FiBrilliN homolog, [RH, Score=268, Expect=2e-72]} {Smed: dd_Smed_v6_2649_0_2, dd_Smed_v6_2649_0_2, [Score=426, Expect=1e-123]} {RNA1509_12396, RNA1509_21908, RNA1509_41091, RNA1509_6746, RNA1509_770} {RNA1310_1209, RNA1509_12396, RNA1509_21908, RNA1509_41091, RNA1509_6746} {RNA1509_12396, RNA1509_21908, RNA1509_41091, RNA1509_6746, RNA815_317.1} |
| 6. | MligTC455_20780 | 8892 | 185.26 | Mlig455_040314 | Neo: - Age: logFC(26M/2M)=-1.054 Region-enriched R8: 6.072/0.00000 |
NOTCH2 | 3.458 | 0.964 | 0.825 | 0.773 | - | - | 0.896 | Mlig455_040314 {REF} {Length: 15786} {Pfam: EGF domain [PF12947.9, score=500.6]; Calcium-binding EGF domain [PF07645.17, score=489.8]; Complement Clr-like EGF-like [PF12662.9, score=268.7]; EGF-like domain [PF00008.29, score=175.9]; Human growth factor-like EGF [PF12661.9, score=135.4]; MSP1 EGF domain 1 [PF12946.9, score=91.5]; von Willebrand factor type D domain [PF00094.27, score=75.8]; Coagulation Factor Xa inhibitory site [PF14670.8, score=51.8]; Pvs28 EGF domain [PF06247.13, score=34.2]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=25.7]} {Human: ENSG00000134250, NOTCH2, notch 2, [Score=246, Expect=4e-64]; ENSG00000138829, FBN2, fibrillin 2, [Score=237, Expect=3e-61]} {Mouse: ENSMUSG00000027878, Notch2, notch 2, [Score=249, Expect=6e-65]} {Dmel: FBgn0053196, dpy, dumpy, [Score=343, Expect=2e-93]} {Celegans: WBGene00022816, fbn-1, FBN-1A.1; FiBrilliN homolog, [RH, Score=254, Expect=5e-67]} {Smed: dd_Smed_v6_2649_0_2, dd_Smed_v6_2649_0_2, [Score=415, Expect=3e-115]} {RNA1509_11248, RNA1509_12416, RNA1509_21118, RNA1509_37363, RNA1509_39736, RNA1509_45308, RNA1509_5454, RNA1509_57584, RNA1509_59762, RNA1509_770, RNA1509_9237} {RNA1310_1209, RNA1509_11248, RNA1509_12416, RNA1509_21118, RNA1509_37363, RNA1509_39736, RNA1509_45308, RNA1509_5454, RNA1509_57584, RNA1509_59762, RNA1509_9237} {RNA1509_11248, RNA1509_12416, RNA1509_21118, RNA1509_37363, RNA1509_39736, RNA1509_45308, RNA1509_5454, RNA1509_57584, RNA1509_59762, RNA1509_9237, RNA815_317.1} |
| 7. | MligTC455_13018 | 1993 | 41.51 | Mlig455_033923 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.482 Region-enriched R8: 5.842/0.00000 |
3.426 | 0.964 | 0.833 | 0.707 | - | - | 0.922 | Mlig455_033923 {REF} {Length: 1258} {RNA1509_17580, RNA1509_20381, RNA1509_25516, RNA1509_52130} {RNA1310_45334, RNA1509_17580, RNA1509_20381, RNA1509_25516, RNA1509_52130} {RNA1509_17580, RNA1509_20381, RNA1509_25516, RNA1509_52130, RNA815_5573.2} | |
| 8. | MligTC455_23517 | 847 | 17.64 | Mlig455_027857 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.877 Region-enriched R8: 5.900/0.00000 |
TLL1 | 3.424 | 0.967 | 0.823 | 0.816 | - | - | 0.818 | Mlig455_027857 {REF} {Length: 1443} {Pfam: Astacin (Peptidase family M12A) [PF01400.26, score=138.1]} {Human: ENSG00000038295, TLL1, tolloid like 1, [Score=95.9, Expect=7e-22]} {Mouse: ENSMUSG00000053626, Tll1, tolloid-like, [Score=94.7, Expect=4e-21]} {Dmel: FBgn0037395, CG10280, [Score=102, Expect=1e-24]} {Celegans: WBGene00003534, nas-15, Zinc metalloproteinase nas-15, [Score=119, Expect=6e-30]} {Smed: dd_Smed_v6_345_0_1, dd_Smed_v6_345_0_1, [RH, Score=124, Expect=7e-34]} {RNA1509_35571} {RNA1310_3360.1} {RNA815_11450} |
| 9. | MligTC455_31518 | 19118 | 398.29 | Mlig455_053864, Mlig455_053878 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=2.053 Region-enriched R8: 7.674/0.00000 |
PI16 | 3.378 | 0.954 | 0.793 | 0.712 | - | - | 0.919 | Mlig455_053864 {REF} {Length: 1794} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=56.1]; Kringle domain [PF00051.20, score=52.3]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=100, Expect=1e-22]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=99.0, Expect=3e-22]} {Dmel: FBgn0038126, CG8483, [Score=102, Expect=1e-23]} {Celegans: WBGene00011724, scl-18, SCP-Like extracellular protein, [RH, Score=73.2, Expect=1e-14]} {Smed: dd_Smed_v6_924_0_1, dd_Smed_v6_924_0_1, [RH, Score=128, Expect=3e-35]} {RNA1509_603} {RNA1310_25676} {RNA815_7928} Mlig455_053878 {REF} {Length: 1368} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=56.1]; Kringle domain [PF00051.20, score=52.3]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=100, Expect=1e-22]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=99.0, Expect=3e-22]} {Dmel: FBgn0038126, CG8483, [Score=102, Expect=1e-23]} {Celegans: WBGene00011724, scl-18, SCP-Like extracellular protein, [RH, Score=73.2, Expect=1e-14]} {Smed: dd_Smed_v6_924_0_1, dd_Smed_v6_924_0_1, [RH, Score=128, Expect=3e-35]} {RNA1509_603} {RNA1310_25676} {RNA815_7928} |
| 10. | MligTC455_31519 | 9556 | 199.07 | Mlig455_055347 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=-0.365 Region-enriched R8: 7.870/0.00000 |
PI16 | 3.377 | 0.954 | 0.793 | 0.711 | - | - | 0.919 | Mlig455_055347 {REF} {Length: 1681} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=56.5]; Kringle domain [PF00051.20, score=52.7]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=84.3, Expect=2e-17]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=82.4, Expect=6e-17]} {Dmel: FBgn0038126, CG8483, [Score=97.4, Expect=2e-22]} {Celegans: WBGene00003055, lon-1, LONg, [Score=65.1, Expect=9e-12]} {Smed: dd_Smed_v6_433_0_1, dd_Smed_v6_433_0_1, [Score=111, Expect=3e-29]} {RNA1509_603} {RNA1310_25676} {RNA815_7928} |
| 11. | MligTC455_31520 | 9547 | 198.9 | Mlig455_055402 | Neo: - Age: logFC(26M/2M)=-0.427 Region-enriched R8: 7.718/0.00000 |
PI16 | 3.377 | 0.954 | 0.793 | 0.711 | - | - | 0.919 | Mlig455_055402 {REF} {Length: 1363} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=27.4]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=69.3, Expect=4e-13]; ENSG00000173401, GLIPR1L1, GLIPR1 like 1, [Score=67.8, Expect=4e-13]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=71.2, Expect=7e-14]} {Dmel: FBgn0038126, CG8483, [Score=55.8, Expect=6e-09]} {Celegans: WBGene00009890, scl-9, SCP-Like extracellular protein, [Score=50.4, Expect=1e-07]} {Smed: dd_Smed_v6_924_0_2, dd_Smed_v6_924_0_2, [Score=87.0, Expect=1e-21]} {RNA1509_603} {RNA1310_25676} {RNA815_7928} |
| 12. | MligTC455_33925 | 519 | 10.82 | Mlig455_020716, Mlig455_020784 | Neo: - Age: Down-Down-Up Region-enriched R8: 6.564/0.00000 |
3.331 | 0.976 | 0.720 | 0.746 | - | - | 0.889 | Mlig455_020716 {REF} {Length: 1635} {Pfam: Amastin surface glycoprotein [PF07344.13, score=21.1]} {RNA1310_25321} {RNA815_36976} Mlig455_020784 {REF} {Length: 2274} {Pfam: Amastin surface glycoprotein [PF07344.13, score=22.1]} {RNA1310_25321} {RNA815_36976} |
|
| 13. | MligTC455_38827 | 168 | 3.49 | Mlig455_065185 | Neo: - Age: - Region-enriched R8: 3.346/0.01415 |
RDX | 2.763 | 0.953 | - | 0.910 | - | - | 0.900 | Mlig455_065185 {REF} {Length: 3409} {Pfam: Ezrin/radixin/moesin family [PF00769.21, score=106.5]; FERM C-terminal PH-like domain [PF09380.12, score=87.8]; FERM central domain [PF00373.20, score=83.0]; FERM N-terminal domain [PF09379.12, score=66.5]} {Human: ENSG00000137710, RDX, radixin, [RH, Score=589, Expect=0.0]; ENSG00000092820, EZR, ezrin, [RH, Score=577, Expect=0.0]; ENSG00000147065, MSN, moesin, [RH, Score=561, Expect=0.0]} {Mouse: ENSMUSG00000032050, Rdx, radixin, [RH, Score=586, Expect=0.0]; ENSMUSG00000031207, Msn, moesin, [RH, Score=557, Expect=0.0]} {Dmel: FBgn0011661, Moe, Moesin, [RH, Score=514, Expect=5e-174]} {Celegans: WBGene00001333, erm-1, ERM-1B; Ezrin/Radixin/Moesin, [Score=545, Expect=0.0]} {Smed: dd_Smed_v6_8101_0_1, dd_Smed_v6_8101_0_1, [Score=504, Expect=7e-172]} {RNA1509_50666} {RNA1310_19690} {RNA815_6880} |
| 14. | MligTC455_07961 | 191 | 3.98 | Mlig455_051526 | Neo: - Age: - Region-enriched R8: 7.862/0.00000 Regeneration-enriched R5: 7.080 |
2.721 | 0.975 | 0.820 | - | - | - | 0.926 | Mlig455_051526 {REF} {Length: 437} {RNA815_63444} | |
| 15. | MligTC455_33475 | 168 | 3.5 | Mlig455_036879 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.551 Region-enriched R8: 7.210/0.00005 |
2.704 | 0.964 | - | 0.792 | - | - | 0.948 | Mlig455_036879 {REF} {Length: 2954} {RNA1509_20567} {RNA1310_1034.1} {RNA815_502.1} | |
| 16. | MligTC455_38796 | 1266 | 26.37 | Mlig455_060220, Mlig455_060235 | Neo: - Age: Down-Down-Up Region-enriched R8: 6.521/0.00003 |
BACE1 | 2.692 | 0.972 | - | 0.789 | - | - | 0.931 | Mlig455_060220 {REF} {Length: 1841} {Pfam: Eukaryotic aspartyl protease [PF00026.25, score=72.8]; Xylanase inhibitor C-terminal [PF14541.8, score=19.9]} {Human: ENSG00000186318, BACE1, beta-secretase 1, [Score=215, Expect=3e-63]} {Mouse: ENSMUSG00000032086, Bace1, beta-site APP cleaving enzyme 1, [Score=214, Expect=5e-63]} {Dmel: FBgn0032304, CG17134, [Score=56.2, Expect=3e-08]} {Celegans: WBGene00000218, asp-5, ASpartyl Protease, [Score=47.8, Expect=1e-05]} {RNA1509_48153} {RNA1310_17192, RNA1509_48153} {RNA1509_48153, RNA815_50706} Mlig455_060235 {REF} {Length: 1482} {Human: ENSG00000186318, BACE1, beta-secretase 1, [Score=119, Expect=2e-29]} {Mouse: ENSMUSG00000032086, Bace1, beta-site APP cleaving enzyme 1, [Score=118, Expect=1e-28]} {RNA1509_48153} {RNA1310_17192} {RNA815_51940} |
| 17. | MligTC455_22921 | 848 | 17.66 | Mlig455_048030 | Neo: - Age: - Region-enriched R8: 6.496/0.00000 Regeneration-downregulated BL: -8.561 Regeneration-depleted BL: -8.561 |
CNTNAP1 | 2.665 | 0.957 | - | 0.807 | - | - | 0.901 | Mlig455_048030 {REF} {Length: 2506} {Pfam: Thrombospondin type 1 domain [PF00090.21, score=31.2]; Spondin-like TSP1 domain [PF19028.2, score=23.9]; Thrombospondin type 1 domain [PF19030.2, score=20.8]} {Human: ENSG00000108797, CNTNAP1, contactin associated protein 1, [Score=65.5, Expect=3e-11]} {Mouse: ENSMUSG00000017167, Cntnap1, contactin associated protein-like 1, [Score=69.3, Expect=1e-12]} {Dmel: FBgn0013997, Nrx-IV, Neurexin IV, [Score=63.5, Expect=6e-11]} {Celegans: WBGene00003772, nlr-1, Neurexin Like receptor, [Score=60.8, Expect=3e-10]} {Smed: dd_Smed_v6_2622_0_1, dd_Smed_v6_2622_0_1, [Score=70.5, Expect=2e-13]} {RNA1509_12135} {RNA1310_13292} {RNA815_6015.1} |
| 18. | MligTC455_20097 | 1223 | 25.49 | Mlig455_023539, Mlig455_023644 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.339 Region-enriched R8: 3.355/0.00001 Regeneration-upregulated BL: 2.571 Regeneration-enriched BL: 2.571 |
2.664 | 0.961 | 0.898 | 0.805 | - | - | - | Mlig455_023539 {REF} {Length: 2548} {TRANSSPLICED} {Pfam: C2H2-type zinc finger [PF13894.8, score=20.7]} {RNA1509_20731} {RNA1310_7206} {RNA815_15099} Mlig455_023644 {REF} {Length: 2780} {Pfam: C2H2-type zinc finger [PF13894.8, score=20.7]} {RNA1509_20731} {RNA1310_7206, RNA1509_20731} {RNA1509_20731, RNA815_15099} |
|
| 19. | MligTC455_44435 | 628 | 13.08 | Mlig455_062382, Mlig455_062409 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=-0.421 Region-enriched R8: 5.635/0.00000 |
DDI2, HMCN1 | 2.652 | 0.972 | 0.812 | - | - | - | 0.868 | Mlig455_062382 {REF} {Length: 12544} {TRANSSPLICED} {Pfam: Aspartyl protease [PF09668.12, score=182.5]; gag-polyprotein putative aspartyl protease [PF13975.8, score=76.1]; Thrombospondin type 1 domain [PF00090.21, score=72.3]; Spondin-like TSP1 domain [PF19028.2, score=68.4]; Arginine repressor, C-terminal domain [PF02863.20, score=43.6]; Aspartyl protease [PF13650.8, score=34.4]; Putative vacuolating cytotoxin [PF03077.16, score=29.0]; Ubiquitin-2 like Rad60 SUMO-like [PF11976.10, score=26.1]; Thrombospondin type 1 domain [PF19030.2, score=23.0]; CCN3 Nov like TSP1 domain [PF19035.2, score=22.2]; Retroviral aspartyl protease [PF00077.22, score=19.1]} {Human: ENSG00000197312, DDI2, DNA damage inducible 1 homolog 2, [Score=279, Expect=2e-82]} {Mouse: ENSMUSG00000078515, Ddi2, DNA-damage inducible protein 2, [Score=266, Expect=5e-78]; ENSMUSG00000047619, Ddi1, DNA-damage inducible 1, [Score=255, Expect=4e-74]} {Dmel: FBgn0030753, rngo, rings lost, [Score=275, Expect=1e-80]} {Celegans: WBGene00015308, ddi-1, Dna (DNA) Damage Inducible homolog, [Score=131, Expect=5e-32]} {Smed: dd_Smed_v6_2764_0_1, dd_Smed_v6_2764_0_1, [Score=213, Expect=1e-60]} {RNA1509_6950} {RNA1310_548} {RNA815_300} Mlig455_062409 {REF} {Length: 19342} {Pfam: Spondin-like TSP1 domain [PF19028.2, score=78.9]; Thrombospondin type 1 domain [PF00090.21, score=74.6]; Arginine repressor, C-terminal domain [PF02863.20, score=41.0]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=40.0]; CCN3 Nov like TSP1 domain [PF19035.2, score=32.2]; Putative vacuolating cytotoxin [PF03077.16, score=30.3]; Thrombospondin type 1 domain [PF19030.2, score=23.2]} {Human: ENSG00000143341, HMCN1, hemicentin 1, [Score=90.1, Expect=7e-17]} {Mouse: ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=90.5, Expect=4e-17]} {Dmel: FBgn0050046, CG30046, [Score=52.4, Expect=8e-06]} {Celegans: WBGene00000083, adt-2, ADAMTS family; ADAMTS-like protease, [Score=87.8, Expect=1e-16]} {Smed: dd_Smed_v6_628_0_1, dd_Smed_v6_628_0_1, [Score=159, Expect=6e-39]} {RNA1509_21415, RNA1509_6950} {RNA1310_548, RNA1509_21415, RNA1509_6950} {RNA1509_21415, RNA1509_6950, RNA815_300} |
| 20. | MligTC455_03038 | 227 | 4.72 | Mlig455_060778 | Neo: - Age: Down-Up-Down Region-enriched R8: 6.261/0.00000 |
2.647 | 0.973 | 0.741 | - | - | - | 0.933 | Mlig455_060778 {REF} {Length: 4155} {TRANSSPLICED} {tRNA: Val(CAC),pseudo, score=27.8} {Mouse: ENSMUSG00000059854, Hydin, HYDIN, axonemal central pair apparatus protein, [Score=55.1, Expect=5e-07]} {RNA1509_16236} {RNA1310_4008} {RNA815_2550} | |
| 21. | MligTC455_12451 | 63 | 1.31 | Mlig455_008444 | Neo: - Age: - Region-enriched R8: 4.645/0.00722 |
2.645 | 0.964 | - | 0.785 | - | - | 0.896 | Mlig455_008444 {REF} {Length: 791} | |
| 22. | MligTC455_49639 | 6233 | 129.85 | Mlig455_022526, Mlig455_022566 | Neo: - Age: - Region-enriched R7: 4.041/0.00000 Regeneration-downregulated BL: -3.756 Regeneration-depleted BL: -3.756 |
2.502 | - | - | 0.725 | 0.806 | - | 0.971 | Mlig455_022526 {REF} {Length: 493} {TRANSSPLICED} {RNA1509_5516} {RNA1310_67929} {RNA815_34597} Mlig455_022566 {REF} {Length: 494} {TRANSSPLICED} {RNA1509_5516} {RNA1310_67929, RNA1509_5516} {RNA1509_5516, RNA815_34597} |
|
| 23. | MligTC455_40223 | 172 | 3.59 | Mlig455_016264 | Neo: - Age: - Region-enriched R8: 3.704/0.01076 |
CHRNA10 | 2.417 | 0.953 | - | 0.708 | - | - | 0.756 | Mlig455_016264 {REF} {Length: 4782} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=169.5]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=109.0]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=230, Expect=2e-68]; ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=225, Expect=1e-66]} {Mouse: ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=233, Expect=9e-70]} {Dmel: FBgn0032151, nAChRalpha6, nicotinic Acetylcholine Receptor alpha6, [Score=236, Expect=2e-70]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=215, Expect=6e-63]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=280, Expect=9e-87]} {RNA1509_35668} {RNA1310_11720.1} {RNA815_6827} |
| 24. | MligTC455_14375 | 163 | 3.4 | Mlig455_056945 | Neo: - Age: - |
1.902 | 0.976 | - | - | - | - | 0.926 | Mlig455_056945 {REF} {Length: 1764} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=49.6]} {Smed: dd_Smed_v6_32358_0_1, dd_Smed_v6_32358_0_1, [Score=94.4, Expect=4e-22]} {RNA1509_48719} {RNA1310_16266.1} {RNA815_10544.2} | |
| 25. | MligTC455_36259 | 270 | 5.63 | Mlig455_012889 | Neo: - Age: - Region-enriched R8: 5.567/0.00000 Regeneration-depleted R6: -6.631 |
WNT7B | 1.88 | 0.954 | - | - | - | - | 0.926 | Mlig455_012889 {REF} {Length: 1741} {Pfam: wnt family [PF00110.21, score=249.8]} {Human: ENSG00000188064, WNT7B, Wnt family member 7B, [Score=153, Expect=3e-42]; ENSG00000105989, WNT2, Wnt family member 2, [Score=149, Expect=2e-40]; ENSG00000002745, WNT16, Wnt family member 16, [Score=147, Expect=1e-39]; ENSG00000154764, WNT7A, Wnt family member 7A, [Score=147, Expect=9e-40]} {Mouse: ENSMUSG00000029671, Wnt16, wingless-type MMTV integration site family, member 16, [Score=155, Expect=5e-43]; ENSMUSG00000022382, Wnt7b, wingless-type MMTV integration site family, member 7B, [Score=152, Expect=4e-42]; ENSMUSG00000022996, Wnt10b, wingless-type MMTV integration site family, member 10B, [Score=150, Expect=7e-41]} {Dmel: FBgn0284084, wg, wingless, [Score=133, Expect=4e-34]} {Celegans: WBGene00001188, egl-20, Wnt homolog, [Score=130, Expect=6e-34]} {Smed: dd_Smed_v6_28398_0_1, dd_Smed_v6_28398_0_1, [Score=214, Expect=3e-65]} {RNA1509_58183} {RNA1310_17932, RNA1509_58183} {RNA1509_58183, RNA815_30269} |
| 26. | MligTC455_04474 | 114 | 2.37 | Mlig455_039605 | Neo: - Age: logFC(26M/2M)=-0.389 Region-enriched R8: 5.608/0.00012 |
HMCN1 | 1.848 | 0.960 | - | - | - | - | 0.888 | Mlig455_039605 {REF} {Length: 4319} {Pfam: Thrombospondin type 1 domain [PF00090.21, score=405.5]; Spondin-like TSP1 domain [PF19028.2, score=340.3]; Thrombospondin type 1 domain [PF19030.2, score=125.1]; Scavenger receptor cysteine-rich domain [PF00530.20, score=57.7]; CCN3 Nov like TSP1 domain [PF19035.2, score=48.4]} {Human: ENSG00000143341, HMCN1, hemicentin 1, [Score=292, Expect=4e-80]} {Mouse: ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=288, Expect=7e-79]} {Dmel: FBgn0284221, Sema5c, Semaphorin 5c, [Score=156, Expect=3e-38]} {Celegans: WBGene00016468, C36B7.5, [RH, Score=199, Expect=7e-52]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=264, Expect=9e-72]} {RNA1509_12135} {RNA1310_3277, RNA1509_12135} {RNA1509_12135, RNA815_5276} |
| 27. | MligTC455_16918 | 1218 | 25.38 | Mlig455_039085, Mlig455_042780 | Neo: - Age: Up-Down-Down Region-enriched R8: 5.308/0.00000 |
MECOM | 1.811 | 0.981 | - | 0.830 | - | - | - | Mlig455_039085 {REF} {Length: 4916} {Pfam: Zinc finger, C2H2 type [PF00096.28, score=99.3]; C2H2-type zinc finger [PF13894.8, score=76.6]; Zinc-finger double domain [PF13465.8, score=72.4]; Zinc-finger double-stranded RNA-binding [PF12171.10, score=41.2]; C2H2-type zinc finger [PF13912.8, score=35.0]; Drought induced 19 protein (Di19), zinc-binding [PF05605.14, score=25.5]; Zinc-finger of C2H2 type [PF12874.9, score=20.9]; C2H2-type zinc-finger domain [PF13909.8, score=18.4]} {Human: ENSG00000085276, MECOM, MDS1 and EVI1 complex locus, [RH, Score=147, Expect=6e-35]; ENSG00000142611, PRDM16, PR/SET domain 16, [RH, Score=145, Expect=3e-34]} {Mouse: ENSMUSG00000027684, Mecom, MDS1 and EVI1 complex locus, [RH, Score=146, Expect=2e-35]; ENSMUSG00000039410, Prdm16, PR domain containing 16, [RH, Score=146, Expect=9e-35]} {Dmel: FBgn0045852, ham, hamlet, [RH, Score=149, Expect=1e-36]} {Celegans: WBGene00015646, mlt-10, [Score=172, Expect=3e-44]} {Smed: dd_Smed_v6_22685_0_1, dd_Smed_v6_22685_0_1, [RH, Score=145, Expect=5e-38]} {RNA1509_21422} {RNA1310_3577} {RNA815_16096} Mlig455_042780 {REF} {Length: 3778} {Pfam: Zinc finger, C2H2 type [PF00096.28, score=70.4]; Zinc-finger double domain [PF13465.8, score=59.4]; C2H2-type zinc finger [PF13894.8, score=36.4]; Drought induced 19 protein (Di19), zinc-binding [PF05605.14, score=29.7]; Zinc-finger double-stranded RNA-binding [PF12171.10, score=29.0]; C2H2-type zinc finger [PF13912.8, score=28.6]; Zinc-finger of C2H2 type [PF12874.9, score=24.8]; C2H2-type zinc-finger domain [PF13909.8, score=21.2]; GAGA factor [PF09237.13, score=19.5]; C2H2 type zinc-finger (2 copies) [PF12756.9, score=18.9]} {Human: ENSG00000085276, MECOM, MDS1 and EVI1 complex locus, [RH, Score=141, Expect=6e-35]; ENSG00000142611, PRDM16, PR/SET domain 16, [RH, Score=139, Expect=3e-34]} {Mouse: ENSMUSG00000027684, Mecom, MDS1 and EVI1 complex locus, [RH, Score=141, Expect=3e-35]; ENSMUSG00000039410, Prdm16, PR domain containing 16, [RH, Score=140, Expect=1e-34]} {Dmel: FBgn0032707, CG10348, [RH, Score=144, Expect=8e-37]} {Celegans: WBGene00001207, egl-43, Egl-43, [RH, Score=98.2, Expect=2e-22]} {Smed: dd_Smed_v6_22685_0_1, dd_Smed_v6_22685_0_1, [RH, Score=144, Expect=9e-39]} {RNA1509_21422} {RNA1310_3577} {RNA815_16096} |
| 28. | MligTC455_39971 | 147 | 3.07 | Mlig455_034549 | Neo: - Age: - Region-enriched R8: 4.475/0.00030 |
1.799 | 0.975 | - | - | - | - | 0.824 | Mlig455_034549 {REF} {Length: 2181} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=33.7]} {RNA1310_27858} {RNA815_17949} | |
| 29. | MligTC455_24861 | 117 | 2.44 | Mlig455_019572 | Neo: - Age: - Region-enriched R8: 4.245/0.00630 |
FREM1 | 1.798 | 0.954 | - | - | - | - | 0.844 | Mlig455_019572 {REF} {Length: 8695} {Pfam: Cadherin-like [PF16184.7, score=328.8]; Frem protein N-terminal domain [PF19309.1, score=92.3]; Lectin C-type domain [PF00059.23, score=31.6]} {Human: ENSG00000164946, FREM1, FRAS1 related extracellular matrix 1, [RH, Score=370, Expect=2e-102]} {Mouse: ENSMUSG00000059049, Frem1, Fras1 related extracellular matrix protein 1, [RH, Score=381, Expect=3e-106]} {Smed: dd_Smed_v6_5187_0_1, dd_Smed_v6_5187_0_1, [RH, Score=508, Expect=4e-147]} {RNA1509_8234} {RNA1310_595.1} {RNA815_322} |
| 30. | MligTC455_35051 | 220 | 4.58 | Mlig455_020175 | Neo: - Age: Down-Up-Down Region-enriched R8: 5.304/0.00000 |
CALM3 | 1.793 | 0.952 | 0.841 | - | - | - | - | Mlig455_020175 {REF} {Length: 927} {Pfam: EF hand [PF00036.34, score=111.3]; EF-hand domain pair [PF13499.8, score=98.6]; EF-hand domain [PF13405.8, score=91.1]; EF-hand domain pair [PF13833.8, score=78.1]; EF hand [PF13202.8, score=76.7]; EF-hand domain [PF14658.8, score=56.1]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=26.7]; Dockerin type I domain [PF00404.20, score=22.0]; EF-hand domain [PF17959.3, score=21.1]} {Human: ENSG00000160014, CALM3, calmodulin 3, [Score=146, Expect=5e-45]; ENSG00000198668, CALM1, calmodulin 1, [Score=146, Expect=5e-45]; ENSG00000143933, CALM2, calmodulin 2, [Score=146, Expect=5e-45]; ENSG00000178363, CALML3, calmodulin like 3, [Score=143, Expect=8e-44]} {Mouse: ENSMUSG00000001175, Calm1, calmodulin 1, [Score=146, Expect=3e-45]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=146, Expect=3e-45]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=146, Expect=3e-45]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=144, Expect=4e-44]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=148, Expect=8e-46]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=147, Expect=7e-46]} {Smed: dd_Smed_v6_255_0_1, dd_Smed_v6_255_0_1, [Score=147, Expect=5e-46]} {RNA1310_46966} {RNA815_26674} |
| 31. | MligTC455_19934 | 704 | 14.66 | Mlig455_001454 | Neo: - Age: - Region-enriched R8: 4.340/0.00000 |
HOXA10 | 1.784 | 0.960 | - | 0.824 | - | - | - | Mlig455_001454 {REF} {Length: 2331} {Pfam: Homeodomain [PF00046.31, score=71.5]; Protein of unknown function (DUF2722) [PF10846.10, score=21.4]; Anti-sigma-K factor rskA [PF10099.11, score=20.2]} {Human: ENSG00000253293, HOXA10, homeobox A10, [RH, Score=97.4, Expect=1e-21]; ENSG00000128713, HOXD11, homeobox D11, [RH, Score=95.5, Expect=2e-21]; ENSG00000170178, HOXD12, homeobox D12, [RH, Score=95.1, Expect=9e-22]; ENSG00000123407, HOXC12, homeobox C12, [RH, Score=94.7, Expect=2e-21]; ENSG00000180818, HOXC10, homeobox C10, [RH, Score=94.4, Expect=6e-21]; ENSG00000005073, HOXA11, homeobox A11, [RH, Score=92.8, Expect=2e-20]; ENSG00000128710, HOXD10, homeobox D10, [RH, Score=92.8, Expect=2e-20]} {Mouse: ENSMUSG00000000938, Hoxa10, homeobox A10, [RH, Score=97.8, Expect=5e-22]; ENSMUSG00000042499, Hoxd11, homeobox D11, [RH, Score=95.9, Expect=1e-21]; ENSMUSG00000050328, Hoxc12, homeobox C12, [RH, Score=94.7, Expect=1e-21]; ENSMUSG00000022484, Hoxc10, homeobox C10, [RH, Score=94.4, Expect=5e-21]; ENSMUSG00000001823, Hoxd12, homeobox D12, [RH, Score=94.4, Expect=1e-21]; ENSMUSG00000050368, Hoxd10, homeobox D10, [RH, Score=93.2, Expect=1e-20]} {Dmel: FBgn0000015, Abd-B, Abdominal B, [RH, Score=106, Expect=7e-25]} {Celegans: WBGene00004024, php-3, Posterior Hox gene Paralog, [RH, Score=104, Expect=2e-25]} {Smed: dd_Smed_v6_9061_0_1, dd_Smed_v6_9061_0_1, [RH, Score=132, Expect=2e-34]} {RNA1509_50329} {RNA1310_36793} {RNA815_27715} |
| 32. | MligTC455_39972 | 142 | 2.96 | Mlig455_064814 | Neo: - Age: - Region-enriched R8: 4.539/0.00054 |
1.765 | 0.975 | - | - | - | - | 0.790 | Mlig455_064814 {REF} {Length: 2232} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=34.6]} {RNA1310_27858} {RNA815_17949} | |
| 33. | MligTC455_28752 | 111 | 2.31 | Mlig455_024556, Mlig455_024588, Mlig455_062242 | Neo: - Age: - Region-enriched R8: 3.725/0.03239 |
1.746 | 0.957 | - | - | - | - | 0.789 | Mlig455_024556 {REF} {Length: 953} {RNA1509_27801} {RNA1310_32897} {RNA815_15953.1} Mlig455_024588 {REF} {Length: 365} {RNA1310_65985} {RNA815_44318} Mlig455_062242 {REF} {Length: 2999} {Pfam: Salt tolerance down-regulator [PF13945.8, score=20.0]} {RNA1509_54152} {RNA1310_6101.1} {RNA815_15953.1} |
|
| 34. | MligTC455_21657 | 84 | 1.76 | Mlig455_048610 | Neo: - Age: - |
LMO1 | 1.737 | 0.974 | - | - | - | - | 0.763 | Mlig455_048610 {REF} {Length: 2071} {Pfam: LIM domain [PF00412.24, score=90.0]} {Human: ENSG00000166407, LMO1, LIM domain only 1, [RH, Score=186, Expect=1e-60]; ENSG00000048540, LMO3, LIM domain only 3, [RH, Score=183, Expect=2e-59]} {Mouse: ENSMUSG00000036111, Lmo1, LIM domain only 1, [RH, Score=183, Expect=1e-59]; ENSMUSG00000030226, Lmo3, LIM domain only 3, [RH, Score=183, Expect=1e-59]} {Dmel: FBgn0265598, Bx, Beadex, [RH, Score=198, Expect=1e-62]} {Celegans: WBGene00002987, lim-4, LIM domain family; Putative transcription factor LIM-4, [Score=79.3, Expect=7e-18]} {Smed: dd_Smed_v6_17422_0_1, dd_Smed_v6_17422_0_1, [RH, Score=140, Expect=6e-42]} {RNA1310_56294} {RNA815_40845} |
| 35. | MligTC455_23599 | 300 | 6.25 | Mlig455_025579 | Neo: - Age: Up-Down-Down Region-enriched R8: 3.645/0.00082 |
FBN2 | 1.735 | 0.955 | 0.780 | - | - | - | - | Mlig455_025579 {REF} {Length: 10696} {Pfam: Calcium-binding EGF domain [PF07645.17, score=312.2]; Complement Clr-like EGF-like [PF12662.9, score=241.1]; Coagulation Factor Xa inhibitory site [PF14670.8, score=125.1]; EGF domain [PF12947.9, score=95.9]; EGF-like domain [PF00008.29, score=59.7]; Human growth factor-like EGF [PF12661.9, score=47.9]; Thrombospondin type 1 domain [PF00090.21, score=28.9]; MSP1 EGF domain 1 [PF12946.9, score=21.3]} {Human: ENSG00000138829, FBN2, fibrillin 2, [Score=250, Expect=2e-65]; ENSG00000166147, FBN1, fibrillin 1, [Score=248, Expect=1e-64]; ENSG00000142449, FBN3, fibrillin 3, [Score=243, Expect=3e-63]} {Mouse: ENSMUSG00000024598, Fbn2, fibrillin 2, [Score=253, Expect=1e-66]; ENSMUSG00000027204, Fbn1, fibrillin 1, [Score=251, Expect=5e-66]} {Dmel: FBgn0035798, frac, faulty attraction, [RH, Score=238, Expect=3e-62]} {Celegans: WBGene00001403, fbl-1, Fibulin-1, [Score=192, Expect=3e-50]} {Smed: dd_Smed_v6_2649_0_2, dd_Smed_v6_2649_0_2, [Score=294, Expect=3e-79]} {RNA1509_13106} {RNA1310_487} {RNA815_5734} |
| 36. | MligTC455_03803 | 364 | 7.58 | Mlig455_053227, Mlig455_065046 | Neo: - Age: Up-Down-Down Region-enriched R7: 3.052/0.00004 Regeneration-downregulated BL: -3.099 Regeneration-depleted BL: -3.099 |
CRACR2A | 1.732 | - | - | 0.952 | - | - | 0.780 | Mlig455_053227 {REF} {Length: 1663} {Pfam: EF-hand domain pair [PF13499.8, score=35.4]; EF-hand domain [PF13405.8, score=31.1]; EF hand [PF00036.34, score=30.6]; EF-hand domain pair [PF13833.8, score=30.3]} {Human: ENSG00000130038, CRACR2A, calcium release activated channel regulator 2A, [Score=142, Expect=1e-38]} {Mouse: ENSMUSG00000061414, Cracr2a, calcium release activated channel regulator 2A, [Score=142, Expect=3e-37]} {Smed: dd_Smed_v6_2966_0_1, dd_Smed_v6_2966_0_1, [Score=168, Expect=5e-47]} {RNA1509_20561} {RNA1310_2186} {RNA815_7541} Mlig455_065046 {REF} {Length: 5354} {TRANSSPLICED} {Pfam: Ras family [PF00071.24, score=173.2]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=108.0]; ADP-ribosylation factor family [PF00025.23, score=64.9]; 50S ribosome-binding GTPase [PF01926.25, score=35.5]; EF-hand domain pair [PF13499.8, score=33.8]; Gtr1/RagA G protein conserved region [PF04670.14, score=30.6]; EF-hand domain [PF13405.8, score=29.1]; EF hand [PF00036.34, score=28.4]; EF-hand domain pair [PF13833.8, score=27.8]; Elongation factor Tu GTP binding domain [PF00009.29, score=21.7]} {Human: ENSG00000130038, CRACR2A, calcium release activated channel regulator 2A, [RH, Score=190, Expect=2e-50]} {Mouse: ENSMUSG00000061414, Cracr2a, calcium release activated channel regulator 2A, [RH, Score=186, Expect=3e-49]} {Dmel: FBgn0051118, RabX4, [Score=156, Expect=2e-43]} {Celegans: WBGene00007067, 4R79.2, Rab-44, [RH, Score=204, Expect=2e-58]} {Smed: dd_Smed_v6_2966_0_1, dd_Smed_v6_2966_0_1, [RH, Score=260, Expect=2e-76]} {RNA1509_20561} {RNA1310_2186, RNA1509_20561} {RNA1509_20561, RNA815_7541} |
| 37. | MligTC455_23598 | 236 | 4.92 | Mlig455_025573 | Neo: - Age: Up-Down-Down Region-enriched R8: 3.347/0.00904 Regeneration-downregulated BL: -7.152 Regeneration-depleted BL: -7.152 |
FBN1 | 1.726 | 0.956 | 0.770 | - | - | - | - | Mlig455_025573 {REF} {Length: 8300} {Pfam: Calcium-binding EGF domain [PF07645.17, score=308.8]; Complement Clr-like EGF-like [PF12662.9, score=240.6]; Coagulation Factor Xa inhibitory site [PF14670.8, score=137.8]; EGF domain [PF12947.9, score=103.1]; EGF-like domain [PF00008.29, score=67.3]; Human growth factor-like EGF [PF12661.9, score=42.0]; Thrombospondin type 1 domain [PF00090.21, score=27.9]; MSP1 EGF domain 1 [PF12946.9, score=23.5]} {Human: ENSG00000166147, FBN1, fibrillin 1, [Score=274, Expect=5e-73]; ENSG00000138829, FBN2, fibrillin 2, [Score=265, Expect=2e-70]; ENSG00000142449, FBN3, fibrillin 3, [Score=263, Expect=1e-69]} {Mouse: ENSMUSG00000027204, Fbn1, fibrillin 1, [Score=291, Expect=2e-78]} {Dmel: FBgn0035798, frac, faulty attraction, [RH, Score=235, Expect=8e-62]} {Celegans: WBGene00001403, fbl-1, Fibulin-1, [Score=165, Expect=2e-41]} {Smed: dd_Smed_v6_2649_0_2, dd_Smed_v6_2649_0_2, [Score=292, Expect=8e-79]} {RNA1509_13106} {RNA1310_487} {RNA815_5734} |
| 38. | MligTC455_37269 | 173 | 3.61 | Mlig455_020047 | Neo: - Age: - |
CASP3 | 1.719 | 0.955 | - | - | - | - | 0.764 | Mlig455_020047 {REF} {Length: 2828} {Pfam: Caspase domain [PF00656.24, score=94.7]; Ankyrin repeats (3 copies) [PF12796.9, score=79.1]; Ankyrin repeats (many copies) [PF13857.8, score=62.0]; Ankyrin repeats (many copies) [PF13637.8, score=58.0]; Ankyrin repeat [PF13606.8, score=40.7]; Ankyrin repeat [PF00023.32, score=31.7]} {Human: ENSG00000164305, CASP3, caspase 3, [Score=111, Expect=1e-26]; ENSG00000003400, CASP10, caspase 10, [Score=107, Expect=9e-24]} {Mouse: ENSMUSG00000031628, Casp3, caspase 3, [Score=106, Expect=5e-25]; ENSMUSG00000025076, Casp7, caspase 7, [Score=106, Expect=7e-25]} {Dmel: FBgn0010501, Dcp-1, Death caspase-1, [Score=96.3, Expect=2e-21]} {Celegans: WBGene00000417, ced-3, Cell death protein 3 Cell death protein 3 subunit 1 Cell death protein 3 subunit 2, [Score=81.6, Expect=9e-17]} {Smed: dd_Smed_v6_10883_0_1, dd_Smed_v6_10883_0_1, [Score=107, Expect=1e-24]} {RNA1509_54818} {RNA1310_7187} {RNA815_8712} |
| 39. | MligTC455_14600 | 206 | 4.29 | Mlig455_038122, Mlig455_039790 | Neo: - Age: - Region-enriched R8: 4.975/0.00049 |
IGFALS | 1.669 | 0.964 | - | - | - | - | 0.705 | Mlig455_038122 {REF} {Length: 2842} {Pfam: Leucine rich repeat [PF13855.8, score=265.7]; Leucine Rich repeats (2 copies) [PF12799.9, score=153.7]; Leucine-rich repeat [PF14580.8, score=67.1]; BspA type Leucine rich repeat region (6 copies) [PF13306.8, score=59.8]; Leucine Rich Repeat [PF00560.35, score=56.6]; Leucine Rich repeat [PF13516.8, score=43.5]} {Human: ENSG00000099769, IGFALS, insulin like growth factor binding protein acid labile subunit, [Score=156, Expect=3e-39]} {Mouse: ENSMUSG00000046070, Igfals, insulin-like growth factor binding protein, acid labile subunit, [RH, Score=160, Expect=8e-41]} {Dmel: FBgn0261269, conv, convoluted, [RH, Score=136, Expect=2e-32]} {Celegans: WBGene00016974, lron-15, ELRR (Extracellular Leucine-Rich Repeat) ONly, [RH, Score=149, Expect=1e-36]} {Smed: dd_Smed_v6_2769_0_1, dd_Smed_v6_2769_0_1, [RH, Score=95.9, Expect=2e-20]} {RNA1310_36223} {RNA815_24524} Mlig455_039790 {REF} {Length: 2820} {Pfam: Leucine rich repeat [PF13855.8, score=265.7]; Leucine Rich repeats (2 copies) [PF12799.9, score=153.7]; Leucine-rich repeat [PF14580.8, score=67.1]; BspA type Leucine rich repeat region (6 copies) [PF13306.8, score=59.8]; Leucine Rich Repeat [PF00560.35, score=56.6]; Leucine Rich repeat [PF13516.8, score=43.5]} {Human: ENSG00000099769, IGFALS, insulin like growth factor binding protein acid labile subunit, [Score=156, Expect=3e-39]} {Mouse: ENSMUSG00000046070, Igfals, insulin-like growth factor binding protein, acid labile subunit, [RH, Score=160, Expect=7e-41]} {Dmel: FBgn0261269, conv, convoluted, [RH, Score=135, Expect=2e-32]} {Celegans: WBGene00016974, lron-15, ELRR (Extracellular Leucine-Rich Repeat) ONly, [RH, Score=149, Expect=1e-36]} {Smed: dd_Smed_v6_2769_0_1, dd_Smed_v6_2769_0_1, [RH, Score=96.3, Expect=2e-20]} {RNA1310_36223} {RNA815_24524} |
| 40. | MligTC455_38303 | 142 | 2.96 | Mlig455_021803 | Neo: - Age: Up-Down-Down |
PCLO | 0.986 | 0.986 | - | - | - | - | - | Mlig455_021803 {REF} {Length: 6090} {Pfam: C2 domain [PF00168.32, score=66.7]; FYVE-type zinc finger [PF02318.18, score=55.2]; Piccolo Zn-finger [PF05715.15, score=27.5]} {Human: ENSG00000186472, PCLO, piccolo presynaptic cytomatrix protein, [RH, Score=122, Expect=6e-27]} {Mouse: ENSMUSG00000061601, Pclo, piccolo (presynaptic cytomatrix protein), [RH, Score=119, Expect=2e-26]} {Dmel: FBgn0053547, Rim, Rab3 interacting molecule, [Score=83.2, Expect=1e-15]} {Celegans: WBGene00004033, pkc-2, Protein kinase C-like 2, [Score=79.0, Expect=1e-14]} {Smed: dd_Smed_v6_9615_0_1, dd_Smed_v6_9615_0_1, [RH, Score=185, Expect=4e-47]} {RNA1509_42665} {RNA1310_6999} {RNA815_17846} |
| 41. | MligTC455_11926 | 101 | 2.11 | Mlig455_021319 | Neo: - Age: - Region-enriched R7: 4.905/0.00107 |
0.976 | 0.976 | - | - | - | - | - | Mlig455_021319 {REF} {Length: 2758} {Pfam: Mab-21 protein [PF03281.16, score=23.9]} {RNA1509_41055} {RNA1310_11481.1} {RNA815_44675} | |
| 42. | MligTC455_46217 | 213 | 4.43 | Mlig455_057532 | Neo: - Age: Down-Up-Down |
RBPMS2 | 0.973 | 0.973 | - | - | - | - | - | Mlig455_057532 {REF} {Length: 5470} {Pfam: RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF00076.24, score=53.4]} {Human: ENSG00000166831, RBPMS2, RNA binding protein, mRNA processing factor 2, [RH, Score=128, Expect=2e-35]} {Mouse: ENSMUSG00000031586, Rbpms, RNA binding protein gene with multiple splicing, [RH, Score=125, Expect=3e-35]} {Dmel: FBgn0263995, cpo, couch potato, [Score=164, Expect=7e-46]} {Celegans: WBGene00003172, mec-8, Mec-8 protein, [Score=124, Expect=4e-33]} {Smed: dd_Smed_v6_4296_0_4, dd_Smed_v6_4296_0_4, [Score=150, Expect=3e-43]} {RNA1509_30119} {RNA1310_16586.1} {RNA815_23894} |
| 43. | MligTC455_05554 | 54 | 1.12 | Mlig455_062512 | Neo: - Age: - |
0.971 | 0.971 | - | - | - | - | - | Mlig455_062512 {REF} {Length: 1169} {RNA1310_55738} {RNA815_31370.1} | |
| 44. | MligTC455_13751 | 141 | 2.93 | Mlig455_066278 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-0.685 Region-enriched R7: 3.016/0.04041 |
0.971 | 0.971 | - | - | - | - | - | Mlig455_066278 {REF} {Length: 3312} {Pfam: Innexin [PF00876.20, score=292.3]} {Dmel: FBgn0027108, Inx2, Innexin 2, [Score=75.9, Expect=1e-14]} {Celegans: WBGene00000488, che-7, Innexin, [Score=193, Expect=7e-55]} {Smed: dd_Smed_v6_15239_0_1, dd_Smed_v6_15239_0_1, [Score=273, Expect=1e-86]} {RNA1509_53271} {RNA1310_13768.1, RNA1509_53271} {RNA1509_53271, RNA815_19062} | |
| 45. | MligTC455_20782 | 91 | 1.9 | Mlig455_066519 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-1.321 Region-enriched R8: 5.950/0.00576 |
0.969 | 0.969 | - | - | - | - | - | Mlig455_066519 {REF} {Length: 3710} {RNA1509_53671} {RNA1310_35957.1} {RNA815_13121.1} | |
| 46. | MligTC455_30986 | 631 | 13.14 | Mlig455_010831, Mlig455_033221 | Neo: - Age: - Region-enriched R7: 2.524/0.00004 Regeneration-downregulated BL: -6.030 Regeneration-depleted BL: -6.030 |
PITPNC1 | 0.967 | 0.967 | - | - | - | - | - | Mlig455_010831 {REF} {Length: 1024} {Pfam: Phosphatidylinositol transfer protein [PF02121.20, score=91.8]} {Human: ENSG00000154217, PITPNC1, phosphatidylinositol transfer protein cytoplasmic 1, [Score=88.6, Expect=3e-21]} {Mouse: ENSMUSG00000040430, Pitpnc1, phosphatidylinositol transfer protein, cytoplasmic 1, [Score=89.0, Expect=1e-21]} {Dmel: FBgn0027872, rdgBbeta, [Score=91.3, Expect=2e-22]} {Celegans: WBGene00010813, pitp-1, PhosphatidylInositol Transfer Protein family, [Score=71.2, Expect=8e-15]} {Smed: dd_Smed_v6_580_0_1, dd_Smed_v6_580_0_1, [Score=65.9, Expect=2e-13]} {RNA1509_38619} {RNA1310_18833} {RNA815_8161} Mlig455_033221 {REF} {Length: 1640} {Pfam: Phosphatidylinositol transfer protein [PF02121.20, score=237.1]} {Human: ENSG00000154217, PITPNC1, phosphatidylinositol transfer protein cytoplasmic 1, [Score=144, Expect=4e-39]} {Mouse: ENSMUSG00000040430, Pitpnc1, phosphatidylinositol transfer protein, cytoplasmic 1, [Score=145, Expect=6e-40]} {Dmel: FBgn0027872, rdgBbeta, [Score=134, Expect=1e-35]} {Celegans: WBGene00010813, pitp-1, PhosphatidylInositol Transfer Protein family, [Score=111, Expect=1e-25]} {Smed: dd_Smed_v6_7211_0_2, dd_Smed_v6_7211_0_2, [Score=114, Expect=6e-27]} {RNA1509_38619} {RNA1310_18833} {RNA815_8161} |
| 47. | MligTC455_48806 | 291 | 6.07 | Mlig455_026095, Mlig455_043131 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.405 Region-enriched R8: 3.032/0.00015 |
TCF4 | 0.962 | 0.962 | - | - | - | - | - | Mlig455_026095 {REF} {Length: 3455} {Pfam: Helix-loop-helix DNA-binding domain [PF00010.28, score=33.4]} {Human: ENSG00000196628, TCF4, transcription factor 4, [RH, Score=157, Expect=2e-40]; ENSG00000140262, TCF12, transcription factor 12, [RH, Score=156, Expect=1e-39]} {Mouse: ENSMUSG00000053477, Tcf4, transcription factor 4, [RH, Score=157, Expect=7e-41]; ENSMUSG00000032228, Tcf12, transcription factor 12, [RH, Score=156, Expect=1e-39]; ENSMUSG00000020167, Tcf3, transcription factor 3, [RH, Score=151, Expect=3e-38]} {Dmel: FBgn0267821, da, daughterless, [Score=148, Expect=5e-37]} {Celegans: WBGene00001949, hlh-2, Helix Loop Helix, [Score=97.8, Expect=1e-21]} {Smed: dd_Smed_v6_5579_0_1, dd_Smed_v6_5579_0_1, [Score=165, Expect=4e-43]} {RNA1310_14993.1} {RNA815_4995.1} Mlig455_043131 {REF} {Length: 3692} {Pfam: Helix-loop-helix DNA-binding domain [PF00010.28, score=41.4]} {Human: ENSG00000196628, TCF4, transcription factor 4, [Score=139, Expect=3e-34]; ENSG00000140262, TCF12, transcription factor 12, [Score=134, Expect=4e-32]; ENSG00000071564, TCF3, transcription factor 3, [Score=133, Expect=5e-32]} {Mouse: ENSMUSG00000053477, Tcf4, transcription factor 4, [Score=139, Expect=1e-34]; ENSMUSG00000032228, Tcf12, transcription factor 12, [Score=134, Expect=2e-32]; ENSMUSG00000020167, Tcf3, transcription factor 3, [Score=134, Expect=1e-32]} {Dmel: FBgn0267821, da, daughterless, [Score=122, Expect=8e-29]} {Celegans: WBGene00001949, hlh-2, Helix Loop Helix, [Score=83.6, Expect=6e-17]} {Smed: dd_Smed_v6_5579_0_1, dd_Smed_v6_5579_0_1, [Score=140, Expect=1e-34]} {RNA1310_14993.1} {RNA815_4995.1} |
| 48. | MligTC455_47410 | 144 | 3 | Mlig455_066471 | Neo: - Age: - |
0.961 | 0.961 | - | - | - | - | - | Mlig455_066471 {REF} {Length: 690} {NoTransDecoderORF} {RNA1509_9488} {RNA1310_3197} {RNA815_3130} | |
| 49. | MligTC455_27718 | 2898 | 60.36 | Mlig455_017369, Mlig455_017453, Mlig455_030941, Mlig455_038743 | Neo: - |
ACTG1 | 0.958 | - | - | - | - | - | 0.958 | Mlig455_017369 {REF} {Length: 1755} {Pfam: Actin [PF00022.21, score=499.7]} {Human: ENSG00000184009, ACTG1, actin gamma 1, [RH, Score=769, Expect=0.0]; ENSG00000075624, ACTB, actin beta, [RH, Score=769, Expect=0.0]; ENSG00000159251, ACTC1, actin, alpha, cardiac muscle 1, [RH, Score=746, Expect=0.0]; ENSG00000163017, ACTG2, actin, gamma 2, smooth muscle, enteric, [RH, Score=745, Expect=0.0]; ENSG00000107796, ACTA2, actin, alpha 2, smooth muscle, aorta, [RH, Score=744, Expect=0.0]; ENSG00000143632, ACTA1, actin, alpha 1, skeletal muscle, [RH, Score=741, Expect=0.0]; ENSG00000169067, ACTBL2, actin, beta like 2, [RH, Score=733, Expect=0.0]} {Mouse: ENSMUSG00000029580, Actb, actin, beta, [RH, Score=769, Expect=0.0]; ENSMUSG00000062825, Actg1, actin, gamma, cytoplasmic 1, [RH, Score=769, Expect=0.0]; ENSMUSG00000068614, Actc1, actin, alpha, cardiac muscle 1, [RH, Score=746, Expect=0.0]; ENSMUSG00000059430, Actg2, actin, gamma 2, smooth muscle, enteric, [RH, Score=745, Expect=0.0]; ENSMUSG00000035783, Acta2, actin, alpha 2, smooth muscle, aorta, [RH, Score=744, Expect=0.0]; ENSMUSG00000031972, Acta1, actin, alpha 1, skeletal muscle, [RH, Score=741, Expect=0.0]; ENSMUSG00000055194, Actbl2, actin, beta-like 2, [RH, Score=739, Expect=0.0]} {Dmel: FBgn0000042, Act5C, Actin 5C, [RH, Score=770, Expect=0.0]} {Celegans: WBGene00000066, act-4, Actin-4, [RH, Score=769, Expect=0.0]} {Smed: dd_Smed_v6_3_0_1, dd_Smed_v6_3_0_1, [RH, Score=759, Expect=0.0]} {RNA1509_819} {RNA1310_20267.2} {RNA815_4929.3} Mlig455_017453 {REF} {Length: 1755} {Pfam: Actin [PF00022.21, score=499.7]} {Human: ENSG00000184009, ACTG1, actin gamma 1, [RH, Score=769, Expect=0.0]; ENSG00000075624, ACTB, actin beta, [RH, Score=769, Expect=0.0]; ENSG00000159251, ACTC1, actin, alpha, cardiac muscle 1, [RH, Score=746, Expect=0.0]; ENSG00000163017, ACTG2, actin, gamma 2, smooth muscle, enteric, [RH, Score=745, Expect=0.0]; ENSG00000107796, ACTA2, actin, alpha 2, smooth muscle, aorta, [RH, Score=744, Expect=0.0]; ENSG00000143632, ACTA1, actin, alpha 1, skeletal muscle, [RH, Score=741, Expect=0.0]; ENSG00000169067, ACTBL2, actin, beta like 2, [RH, Score=733, Expect=0.0]} {Mouse: ENSMUSG00000029580, Actb, actin, beta, [RH, Score=769, Expect=0.0]; ENSMUSG00000062825, Actg1, actin, gamma, cytoplasmic 1, [RH, Score=769, Expect=0.0]; ENSMUSG00000068614, Actc1, actin, alpha, cardiac muscle 1, [RH, Score=746, Expect=0.0]; ENSMUSG00000059430, Actg2, actin, gamma 2, smooth muscle, enteric, [RH, Score=745, Expect=0.0]; ENSMUSG00000035783, Acta2, actin, alpha 2, smooth muscle, aorta, [RH, Score=744, Expect=0.0]; ENSMUSG00000031972, Acta1, actin, alpha 1, skeletal muscle, [RH, Score=741, Expect=0.0]; ENSMUSG00000055194, Actbl2, actin, beta-like 2, [RH, Score=739, Expect=0.0]} {Dmel: FBgn0000042, Act5C, Actin 5C, [RH, Score=770, Expect=0.0]} {Celegans: WBGene00000066, act-4, Actin-4, [RH, Score=769, Expect=0.0]} {Smed: dd_Smed_v6_3_0_1, dd_Smed_v6_3_0_1, [RH, Score=759, Expect=0.0]} {RNA1509_819} {RNA1310_20267.2, RNA1509_819} {RNA1509_819, RNA815_4929.3} Mlig455_030941 {REF} {Length: 1755} {Pfam: Actin [PF00022.21, score=499.7]} {Human: ENSG00000184009, ACTG1, actin gamma 1, [RH, Score=769, Expect=0.0]; ENSG00000075624, ACTB, actin beta, [RH, Score=769, Expect=0.0]; ENSG00000159251, ACTC1, actin, alpha, cardiac muscle 1, [RH, Score=746, Expect=0.0]; ENSG00000163017, ACTG2, actin, gamma 2, smooth muscle, enteric, [RH, Score=745, Expect=0.0]; ENSG00000107796, ACTA2, actin, alpha 2, smooth muscle, aorta, [RH, Score=744, Expect=0.0]; ENSG00000143632, ACTA1, actin, alpha 1, skeletal muscle, [RH, Score=741, Expect=0.0]; ENSG00000169067, ACTBL2, actin, beta like 2, [RH, Score=733, Expect=0.0]} {Mouse: ENSMUSG00000029580, Actb, actin, beta, [RH, Score=769, Expect=0.0]; ENSMUSG00000062825, Actg1, actin, gamma, cytoplasmic 1, [RH, Score=769, Expect=0.0]; ENSMUSG00000068614, Actc1, actin, alpha, cardiac muscle 1, [RH, Score=746, Expect=0.0]; ENSMUSG00000059430, Actg2, actin, gamma 2, smooth muscle, enteric, [RH, Score=745, Expect=0.0]; ENSMUSG00000035783, Acta2, actin, alpha 2, smooth muscle, aorta, [RH, Score=744, Expect=0.0]; ENSMUSG00000031972, Acta1, actin, alpha 1, skeletal muscle, [RH, Score=741, Expect=0.0]; ENSMUSG00000055194, Actbl2, actin, beta-like 2, [RH, Score=739, Expect=0.0]} {Dmel: FBgn0000042, Act5C, Actin 5C, [RH, Score=770, Expect=0.0]} {Celegans: WBGene00000066, act-4, Actin-4, [RH, Score=769, Expect=0.0]} {Smed: dd_Smed_v6_3_0_1, dd_Smed_v6_3_0_1, [RH, Score=759, Expect=0.0]} {RNA1509_19403, RNA1509_33717, RNA1509_819} {RNA1310_20267.2, RNA1509_19403, RNA1509_33717} {RNA1509_19403, RNA1509_33717, RNA815_4929.3} Mlig455_038743 {REF} {Length: 235} {RNA1310_23291.2} {RNA815_33940} |
| 50. | MligTC455_37871 | 805 | 16.78 | Mlig455_004524 | Neo: - Age: Up-Down-Up Region-specific R4: 1.756 Region-enriched R4: 2.463/0.00000 Regeneration-upregulated TP: 2.142 Regeneration-enriched TP: 2.142 |
HMGB1 | 0.958 | - | - | - | - | - | 0.958 | Mlig455_004524 {REF} {Length: 3515} {Pfam: HMG (high mobility group) box [PF00505.21, score=130.7]; HMG-box domain [PF09011.12, score=110.0]} {Human: ENSG00000189403, HMGB1, high mobility group box 1, [Score=167, Expect=8e-52]; ENSG00000164104, HMGB2, high mobility group box 2, [Score=161, Expect=1e-49]} {Mouse: ENSMUSG00000066551, Hmgb1, high mobility group box 1, [RH, Score=162, Expect=1e-50]} {Dmel: FBgn0278608, Dsp1, Dorsal switch protein 1, [Score=187, Expect=3e-58]} {Celegans: WBGene00001972, hmg-1.2, High mobility group protein 1.2, [Score=147, Expect=2e-44]} {Smed: dd_Smed_v6_1331_0_1, dd_Smed_v6_1331_0_1, [RH, Score=237, Expect=5e-79]} {RNA1509_561} {RNA1310_15889.1} {RNA815_4632} |
| 51. | MligTC455_49843 | 70 | 1.46 | Mlig455_058264, Mlig455_058281, Mlig455_070786 | Neo: - Age: - |
CHRNA3, CHRNA7 | 0.957 | 0.957 | - | - | - | - | - | Mlig455_058264 {REF} {Length: 2377} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=149.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=103.7]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=224, Expect=4e-66]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=216, Expect=2e-63]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=223, Expect=8e-66]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=220, Expect=8e-65]; ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=219, Expect=6e-65]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=213, Expect=4e-62]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=240, Expect=3e-72]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=229, Expect=7e-69]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=227, Expect=1e-67]} {RNA1310_31785} {RNA815_40862} Mlig455_058281 {REF} {Length: 2912} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=179.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=105.5]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=239, Expect=1e-71]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=239, Expect=1e-71]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=238, Expect=4e-71]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=236, Expect=1e-70]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=231, Expect=2e-69]; ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=229, Expect=4e-68]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=240, Expect=3e-72]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=232, Expect=3e-69]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=231, Expect=7e-69]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=228, Expect=3e-68]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=252, Expect=2e-76]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=250, Expect=1e-76]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=239, Expect=7e-72]} {RNA1310_31785} {RNA815_40862} Mlig455_070786 {REF} {Length: 1486} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=36.1]} {RNA1310_31785} {RNA815_43410} |
| 52. | MligTC455_38828 | 995 | 20.73 | Mlig455_009774, Mlig455_054924 | Neo: - Age: Down-Up-Down Region-enriched R8: 1.773/0.01787 |
CELSR2 | 0.955 | 0.955 | - | - | - | - | - | Mlig455_009774 {REF} {Length: 2779} {Pfam: Cadherin domain [PF00028.19, score=114.6]} {Human: ENSG00000143126, CELSR2, cadherin EGF LAG seven-pass G-type receptor 2, [Score=110, Expect=3e-24]} {Mouse: ENSMUSG00000068740, Celsr2, cadherin, EGF LAG seven-pass G-type receptor 2, [Score=107, Expect=3e-23]} {Dmel: FBgn0039294, Cad96Cb, Cadherin 96Cb, [RH, Score=133, Expect=7e-32]} {Celegans: WBGene00000401, cdh-9, CaDHerin family, [RH, Score=79.7, Expect=3e-15]} {Smed: dd_Smed_v6_14410_0_1, dd_Smed_v6_14410_0_1, [Score=77.0, Expect=2e-14]} {RNA1509_6574} {RNA1310_7530, RNA1509_6574} {RNA1509_6574, RNA815_2409} Mlig455_054924 {REF} {Length: 2736} {Pfam: Cadherin domain [PF00028.19, score=113.4]} {Human: ENSG00000143126, CELSR2, cadherin EGF LAG seven-pass G-type receptor 2, [Score=108, Expect=1e-23]} {Mouse: ENSMUSG00000068740, Celsr2, cadherin, EGF LAG seven-pass G-type receptor 2, [Score=104, Expect=2e-22]} {Dmel: FBgn0039294, Cad96Cb, Cadherin 96Cb, [RH, Score=130, Expect=5e-31]} {Celegans: WBGene00000401, cdh-9, CaDHerin family, [RH, Score=82.8, Expect=3e-16]} {Smed: dd_Smed_v6_14410_0_1, dd_Smed_v6_14410_0_1, [Score=78.2, Expect=9e-15]} {RNA1509_57757, RNA1509_6574} {RNA1310_7530, RNA1509_57757} {RNA1509_57757, RNA815_2409} |
| 53. | MligTC455_42157 | 340 | 7.09 | Mlig455_025121 | Neo: - Age: - |
0.955 | 0.955 | - | - | - | - | - | Mlig455_025121 {REF} {Length: 5069} {Smed: dd_Smed_v6_4268_0_1, dd_Smed_v6_4268_0_1, [RH, Score=76.6, Expect=7e-16]} {RNA1509_57041, RNA1509_57438} {RNA1310_30507, RNA1509_57041} {RNA1509_57041, RNA815_19089} | |
| 54. | MligTC455_27571 | 65 | 1.36 | Mlig455_035134 | Neo: - Age: logFC(26M/2M)=-0.443 Region-enriched R7: 3.058/0.04041 Regeneration-downregulated TP: -8.493 Regeneration-depleted TP: -8.493 |
ANK1 | 0.954 | 0.954 | - | - | - | - | - | Mlig455_035134 {REF} {Length: 4051} {Pfam: Ankyrin repeat [PF00023.32, score=192.6]; Ankyrin repeats (3 copies) [PF12796.9, score=186.4]; Ankyrin repeat [PF13606.8, score=143.1]; Ankyrin repeats (many copies) [PF13637.8, score=131.9]; Ankyrin repeats (many copies) [PF13857.8, score=129.4]; Mab-21 protein [PF03281.16, score=28.2]; Glutamine amidotransferase domain [PF13537.8, score=28.0]; PEGA domain [PF08308.13, score=20.0]} {Human: ENSG00000029534, ANK1, ankyrin 1, [Score=183, Expect=3e-46]} {Mouse: ENSMUSG00000031543, Ank1, ankyrin 1, erythroid, [Score=179, Expect=2e-45]} {Dmel: FBgn0261788, Ank2, Ankyrin 2, [Score=173, Expect=2e-43]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=172, Expect=3e-43]} {Smed: dd_Smed_v6_10835_0_2, dd_Smed_v6_10835_0_2, [Score=179, Expect=1e-45]} {RNA1509_26004} {RNA1310_3906.1} {RNA815_1664.1} |
| 55. | MligTC455_22445 | 581 | 12.1 | Mlig455_000365, Mlig455_046128, Mlig455_051768, Mlig455_056483 | Neo: - Age: - |
0.953 | - | - | - | - | - | 0.953 | Mlig455_000365 {REF} {Length: 7344} {RNA1509_26358} {RNA1310_19270} {RNA815_9662} Mlig455_046128 {REF} {Length: 3741} {NoTransDecoderORF} {RNA1509_51930} {RNA1310_30917} {RNA815_9662} Mlig455_051768 {REF} {Length: 1926} {NoTransDecoderORF} {RNA1509_51930} {RNA1310_30917} {RNA815_9662} Mlig455_056483 {REF} {Length: 2175} {RNA1310_39289} {RNA815_16790} |
|
| 56. | MligTC455_11123 | 37 | 0.77 | Mlig455_032334 | Neo: - Age: Down-Up-Up |
0.952 | - | - | - | - | - | 0.952 | Mlig455_032334 {REF} {Length: 4865} {Pfam: PAS domain [PF13188.9, score=19.3]} {RNA1509_56926} {RNA1310_51110.1} {RNA815_20842.1} | |
| 57. | MligTC455_30420 | 109 | 2.28 | Mlig455_054202, Mlig455_060746 | Neo: - Age: - |
TMEM26 | 0.952 | 0.952 | - | - | - | - | - | Mlig455_054202 {REF} {Length: 2118} {Pfam: Transmembrane protein 26 [PF09772.11, score=227.2]} {Human: ENSG00000196932, TMEM26, transmembrane protein 26, [Score=126, Expect=7e-33]} {Mouse: ENSMUSG00000060044, Tmem26, transmembrane protein 26, [RH, Score=134, Expect=7e-36]} {Dmel: FBgn0039429, CG14238, [Score=172, Expect=5e-49]} {Celegans: WBGene00022469, Y119C1B.3, [Score=139, Expect=2e-37]} {Smed: dd_Smed_v6_30929_0_1, dd_Smed_v6_30929_0_1, [Score=144, Expect=1e-39]} {RNA1310_35836} {RNA815_14435} Mlig455_060746 {REF} {Length: 3939} {Pfam: Transmembrane protein 26 [PF09772.11, score=226.7]} {Human: ENSG00000196932, TMEM26, transmembrane protein 26, [Score=127, Expect=5e-33]} {Mouse: ENSMUSG00000060044, Tmem26, transmembrane protein 26, [RH, Score=136, Expect=1e-36]} {Dmel: FBgn0039429, CG14238, [Score=171, Expect=8e-49]} {Celegans: WBGene00022469, Y119C1B.3, [Score=139, Expect=2e-37]} {Smed: dd_Smed_v6_30929_0_1, dd_Smed_v6_30929_0_1, [Score=144, Expect=1e-39]} {RNA1310_35836} {RNA815_14435} |
| 58. | MligTC455_52587 | 3302 | 68.8 | Mlig455_026018 | Neo: - Age: logFC(26M/2M)=-0.478 Region-enriched R7: 4.779/0.00000 Regeneration-depleted BL: -3.978 |
0.952 | - | - | - | - | - | 0.952 | Mlig455_026018 {REF} {Length: 2708} {Pfam: Tissue inhibitor of metalloproteinase [PF00965.19, score=39.4]; UNC-6/NTR/C345C module [PF01759.23, score=22.8]} {RNA1509_3446} {RNA1310_19915.1} {RNA815_10703.1} | |
| 59. | MligTC455_28497 | 107 | 2.23 | Mlig455_062454 | Neo: - Age: - Region-enriched R7: 3.384/0.00125 |
0.95 | - | - | - | - | - | 0.950 | Mlig455_062454 {REF} {Length: 4513} {Pfam: Zinc-binding domain [PF13695.8, score=70.3]} {Smed: dd_Smed_v6_4477_0_1, dd_Smed_v6_4477_0_1, [Score=76.3, Expect=3e-15]} {RNA1509_52092} {RNA1310_11003.1} {RNA815_6825.1} | |
| 60. | MligTC455_30985 | 442 | 9.22 | Mlig455_010824 | Neo: - Age: Down-Up-Down Region-enriched R7: 2.207/0.00023 Regeneration-downregulated BL: -3.092 Regeneration-depleted BL: -3.092 |
0.95 | 0.950 | - | - | - | - | - | Mlig455_010824 {REF} {Length: 2717} {Pfam: Pao retrotransposon peptidase [PF05380.15, score=178.4]; Family of unknown function (DUF5641) [PF18701.3, score=106.4]; Integrase zinc binding domain [PF17921.3, score=34.3]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=32.6]} {Celegans: WBGene00044435, Y20F4.8, [Score=64.7, Expect=9e-11]} {Smed: dd_Smed_v6_22202_0_1, dd_Smed_v6_22202_0_1, [RH, Score=119, Expect=5e-31]} {RNA1509_9219} {RNA1310_468} {RNA815_355.1} |